BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36864007)

  • 1. Frequent EGFR exon 20 insertion in the so-called peripheral-type squamous cell neoplasm of uncertain malignant potential: a variant of bronchiolar adenoma or under-recognised entity?
    Zheng Q; Hou L; Shang G; Qi X; Zhang M; Jin Y; Wang Y; Xue Q; Wu C; Li Y
    Histopathology; 2023 Aug; 83(2):178-192. PubMed ID: 36864007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchiolar Adenoma: Expansion of the Concept of Ciliated Muconodular Papillary Tumors With Proposal for Revised Terminology Based on Morphologic, Immunophenotypic, and Genomic Analysis of 25 Cases.
    Chang JC; Montecalvo J; Borsu L; Lu S; Larsen BT; Wallace WD; Sae-Ow W; Mackinnon AC; Kim HR; Bowman A; Sauter JL; Arcila ME; Ladanyi M; Travis WD; Rekhtman N
    Am J Surg Pathol; 2018 Aug; 42(8):1010-1026. PubMed ID: 29846186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of stratified bronchiolar adenoma with immunofluorescence analysis: comments on "Frequent EGFR exon 20 insertion in the so-called peripheral type squamous cell neoplasm of uncertain malignant potential: a variant of bronchiolar adenoma or under-recognized entity?".
    Sugimoto A; Hirata M; Jinnouchi K; Ohata K; Kikuchi R; Haga H; Yoshizawa A
    Histopathology; 2024 Feb; 84(3):570-573. PubMed ID: 37849413
    [No Abstract]   [Full Text] [Related]  

  • 4. A clinicopathologic and molecular analysis of five cases of bronchiolar adenoma with rare mutations.
    Takeda-Miyata N; Miyagawa-Hayashino A; Hamada S; Nagamine M; Fujii T; Imura T; Tsunezuka H; Shimomura M; Yamaguchi T; Yanada M; Inoue M; Konishi E
    Pathol Int; 2022 May; 72(5):273-282. PubMed ID: 35234319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKT1 Mutations in Peripheral Bronchiolar Papilloma: Glandular Papilloma and Mixed Squamous Cell and Glandular Papilloma Is Distinct From Bronchiolar Adenoma.
    Sasaki E; Masago K; Fujita S; Iwakoshi A; Kuroda H; Hosoda W
    Am J Surg Pathol; 2021 Jan; 45(1):119-126. PubMed ID: 32868527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological, immunohistochemical, and genetic analyses of bronchiolar adenoma and its putative variants.
    Shao J; Yin JC; Bao H; Zhao R; Han Y; Zhu L; Wu X; Shao Y; Zhang J
    J Pathol Clin Res; 2021 May; 7(3):287-300. PubMed ID: 33400370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distal-type bronchiolar adenoma of the lung harboring an EGFR exon 21 p.L858R mutation: A case report.
    Yang C; Wang X; Da J; Ma K
    Thorac Cancer; 2020 Dec; 11(12):3596-3598. PubMed ID: 33063939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological characteristics and molecular analysis of lung cancer associated with ciliated muconodular papillary tumor/bronchiolar adenoma.
    Higashiyama M; Motoi N; Yotsukura M; Yoshida Y; Nakagawa K; Yagishita S; Shirasawa M; Yoshida T; Shiraishi K; Kohno T; Ohe Y; Watanabe SI
    Pathol Int; 2023 May; 73(5):188-197. PubMed ID: 36896472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchiolar adenoma with squamous metaplasia: a distinct phenotype.
    Teng X; Chen Z; Zhang L; Teng X
    Histopathology; 2023 Aug; 83(2):193-201. PubMed ID: 36971378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study.
    Bircan S; Baloglu H; Kucukodaci Z; Bircan A
    Med Oncol; 2014 Aug; 31(8):87. PubMed ID: 24973952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions.
    Oxnard GR; Lo PC; Nishino M; Dahlberg SE; Lindeman NI; Butaney M; Jackman DM; Johnson BE; Jänne PA
    J Thorac Oncol; 2013 Feb; 8(2):179-84. PubMed ID: 23328547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between EGFR and KRAS mutations and prognosis in Chinese patients with non-small cell lung cancer: a mutation analysis with real-time polymerase chain reaction using scorpion amplification refractory mutation system].
    Gao J; Chen JQ; Zhang L; Liang ZY
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):652-6. PubMed ID: 23302304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIF5B/RET fusion gene in surgically-treated adenocarcinoma of the lung.
    Yokota K; Sasaki H; Okuda K; Shimizu S; Shitara M; Hikosaka Y; Moriyama S; Yano M; Fujii Y
    Oncol Rep; 2012 Oct; 28(4):1187-92. PubMed ID: 22797671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer.
    Patil T; Mushtaq R; Marsh S; Azelby C; Pujara M; Davies KD; Aisner DL; Purcell WT; Schenk EL; Pacheco JM; Bunn PA; Camidge DR; Doebele RC
    Clin Lung Cancer; 2020 May; 21(3):e191-e204. PubMed ID: 31859066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Driver mutations among never smoking female lung cancer tissues in China identify unique EGFR and KRAS mutation pattern associated with household coal burning.
    Hosgood HD; Pao W; Rothman N; Hu W; Pan YH; Kuchinsky K; Jones KD; Xu J; Vermeulen R; Simko J; Lan Q
    Respir Med; 2013 Nov; 107(11):1755-62. PubMed ID: 24055406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations.
    Rekhtman N; Paik PK; Arcila ME; Tafe LJ; Oxnard GR; Moreira AL; Travis WD; Zakowski MF; Kris MG; Ladanyi M
    Clin Cancer Res; 2012 Feb; 18(4):1167-76. PubMed ID: 22228640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas.
    Van Damme N; Deron P; Van Roy N; Demetter P; Bols A; Van Dorpe J; Baert F; Van Laethem JL; Speleman F; Pauwels P; Peeters M
    BMC Cancer; 2010 May; 10():189. PubMed ID: 20459770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic Significance of EGFR Mutation and HPV Infection in Sinonasal Squamous Cell Carcinoma.
    Hongo T; Yamamoto H; Jiromaru R; Nozaki Y; Yasumatsu R; Hashimoto K; Yoneda R; Sugii A; Taguchi K; Masuda M; Nakagawa T; Oda Y
    Am J Surg Pathol; 2021 Jan; 45(1):108-118. PubMed ID: 32868526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features and genomic analysis of bronchiolar adenoma.
    Bo J; Chen X; Zhang T; Zhu X; Zhang L; Liu Y; Zhang H; Wu C; Mou S; Yi X; Rui W; Zeng Y
    Histol Histopathol; 2023 Dec; 38(12):1465-1474. PubMed ID: 36988010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.
    Liu Y; Wu BQ; Zhong HH; Hui P; Fang WG
    Int J Clin Exp Pathol; 2013; 6(9):1880-9. PubMed ID: 24040454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.